{
    "Trade/Device Name(s)": [
        "Nano-CheckTM AMI 3 IN 1 Cardiac Marker Test cTnl, CK-MB and Myoglobin"
    ],
    "Submitter Information": "Nano-Ditech Co.",
    "510(k) Number": "K050975",
    "Predicate Device Reference 510(k) Number(s)": [
        "K030057"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI",
        "JHT",
        "DDR"
    ],
    "Summary Letter Date": "March 2, 2006",
    "Summary Letter Received Date": "February 22, 2006",
    "Submission Date": "February 21, 2006",
    "Regulation Number(s)": [
        "21CFR862.1215"
    ],
    "Regulation Name(s)": [
        "Creatine phosphokinase/creatine kinase or isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cardiac Troponin I (cTnI)",
        "Creatine Kinase MB (CK-MB)",
        "Myoglobin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay",
        "Lateral flow"
    ],
    "Methodologies": [
        "Qualitative immunoassay",
        "Lateral flow immunochromatography"
    ],
    "Submission Type(s)": [
        "Test",
        "Cassette",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Nano-Check AMI 3 IN 1 Cardiac Marker Test for qualitative detection of cTnI, CK-MB, and Myoglobin using immunochromatographic cassette format.",
    "Indications for Use Summary": "Qualitative, rapid immunoassay for cTnI, CK-MB, and Myoglobin in human serum and plasma, as an aid in the diagnosis of acute myocardial infarction (AMI).",
    "fda_folder": "Clinical Chemistry"
}